Association Between Atazanavir‐Induced Hyperbilirubinemia and Cardiovascular Disease in Patients Infected with HIV

BACKGROUND: Serum bilirubin is inversely associated with cardiovascular risk. Atazanavir, an HIV protease inhibitor that competitively inhibits bilirubin conjugation, provides a unique opportunity to examine whether selectively increasing bilirubin is cardioprotective. We sought to determine whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Michael, Chan, Walter W., Zucker, Stephen D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792387/
https://www.ncbi.nlm.nih.gov/pubmed/32930032
http://dx.doi.org/10.1161/JAHA.120.016310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792387/
https://www.ncbi.nlm.nih.gov/pubmed/32930032
http://dx.doi.org/10.1161/JAHA.120.016310

Ejemplares similares